INDUCTION AND REGULATION OF IMMUNE NEPHRITIS
免疫性肾炎的诱导和调节
基本信息
- 批准号:3086238
- 负责人:
- 金额:$ 7.69万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1984
- 资助国家:美国
- 起止时间:1984-07-01 至 1987-06-16
- 项目状态:已结题
- 来源:
- 关键词:B lymphocyte T lymphocyte affinity chromatography antiantibody antiidiotype antibody autoimmune disorder basement membrane genetic strain glomerulonephritis humoral immunity hybridomas immunofluorescence technique immunoglobulin genes immunoregulation interstitial nephritis monoclonal antibody radioimmunoassay renal tubule
项目摘要
This project seeks to utilize didactic and research experiences to provide
a program for the development of an effective independent investigator in
the field of renal immunology. Phase 1 will establish an educational
foundation as well as create a formulative research and methodologic
experience. the former will be accomplished through seminars in the
Immunology Graduate Group, lectures, conferences, and journal clubs. The
latter will evolve from the further study of an already operational model
of anti-tubular basement membrane (AlphaTBM) disease producing interstitial
nephritis in mice. This project will initially examine the qualitative and
quantitative aspects of the AlphaTBM B cell repertoire. Such an analysis
will require the generation of a library of monoclonal AlphaTMB antibodies
(AlphaTBM-Ab), as well as an evaluation of B cell precursor frequencies.
The immunogenetics of the B cell response will be examined utilizing
congenic mice to assess the relationship between heavy-chain allotype,
haplotype, paratypic and idiotypic composition of AlphaTBM-Ab, and disease
susceptibility. Further analysis of the immunoregulation of AlphaTBM
disease will examine both the humoral and cellular arms of the idiotypic
network and will employ anti-idiotypic antisera to polymorphic and broadly
cross-reactive idiotypes. Solid phase radioimmunoassay will be used
extensively to allow a fine analysis of the AlphaTBM serology. Finally,
the further purification of nephritogenic TBM antigens will utilize
monoclonal AlphaTBM-Ab affinity columns and an intensive analytical
biochemical approach to isolate distinct epitopes.
At the conclusion of Phase 1, it is anticipated that a more independent
effort will be undertaken. This will consist of a detailed analysis of the
afferent and immunoregulatory phase of experimental membranous nephritis, a
model analogous to one of the most common causes of adult nephrotic
syndrome. Since the relevant antigen can be readily isolated, and because
the antibody response is critical to the nephritogenic immune response,
many of the studies outlined for Phase 1 should be both feasible and easily
applicable. A detailed immunogenetic analysis will be undertaken utilizing
congenic rodents and variables described for AlphaTBM disease above. In
sum, it is felt that Phase 2 has great potential to further understanding
regarding induction and control of this experimental form of membranous
glomerulonephritis.
该项目旨在利用教学和研究经验,
一个有效的独立调查员的发展计划,
肾脏免疫学领域。 第一阶段将建立一个教育
基础,并创建一个公式化的研究和方法论
体验. 前一项工作将通过在
免疫学研究生组,讲座,会议和期刊俱乐部。 的
后者将从对一个已经运作的模型的进一步研究中发展而来
抗肾小管基底膜(AlphaTBM)疾病产生间质性
小鼠肾炎。 该项目将首先审查质量和
AlphaTBM B细胞库的定量方面。 这种分析
将需要产生单克隆AlphaTMB抗体文库
(AlphaTBM-Ab),以及评估B细胞前体频率。
B细胞应答的免疫遗传学将利用
同类小鼠来评估重链同种异型之间的关系,
AlphaTBM-Ab单倍型、特异性和独特型组成与疾病
易感性 进一步分析AlphaTBM的免疫调节作用
疾病将检查独特型的体液和细胞臂
网络,并将采用抗独特型抗血清多态性和广泛
交叉反应的独特型。 将使用固相放射免疫测定法
以允许对AlphaTBM血清学进行精细分析。 最后,
致肾炎性TBM抗原的进一步纯化将利用
单克隆AlphaTBM-Ab亲和柱和一个密集的分析
生物化学方法分离不同的表位。
在第一阶段结束时,预计将有一个更加独立的
将作出努力。 这将包括详细分析
实验性膜性肾炎的传入和免疫调节相
模型类似于成人肾病最常见的原因之一,
综合征 因为相关抗原可以容易地分离,并且因为
抗体应答对于致肾炎免疫应答是关键的,
第一阶段概述的许多研究应该既可行又容易
适用因 详细的免疫遗传学分析将利用
同类啮齿动物和上述AlphaTBM疾病的变量。 在
总之,我们认为第二阶段有很大潜力进一步了解
关于诱导和控制这种实验形式的膜
肾小球肾炎
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MICHAEL D CLAYMAN其他文献
MICHAEL D CLAYMAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MICHAEL D CLAYMAN', 18)}}的其他基金
相似海外基金
Modulation of T lymphocyte Activation by Ã2-Adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
RGPIN-2019-06980 - 财政年份:2022
- 资助金额:
$ 7.69万 - 项目类别:
Discovery Grants Program - Individual
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
- 批准号:
10581488 - 财政年份:2022
- 资助金额:
$ 7.69万 - 项目类别:
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574979-2022 - 财政年份:2022
- 资助金额:
$ 7.69万 - 项目类别:
University Undergraduate Student Research Awards
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
- 批准号:
10332251 - 财政年份:2022
- 资助金额:
$ 7.69万 - 项目类别:
Modulation of T lymphocyte Activation by Ã2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574984-2022 - 财政年份:2022
- 资助金额:
$ 7.69万 - 项目类别:
University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574985-2022 - 财政年份:2022
- 资助金额:
$ 7.69万 - 项目类别:
University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by Ã2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574978-2022 - 财政年份:2022
- 资助金额:
$ 7.69万 - 项目类别:
University Undergraduate Student Research Awards
Investigating the cell-based activity of a new class of cytotoxic T-lymphocyte antigen-4 (CTLA-4) small molecule inhibitors
研究一类新型细胞毒性 T 淋巴细胞抗原 4 (CTLA-4) 小分子抑制剂的细胞活性
- 批准号:
444149 - 财政年份:2021
- 资助金额:
$ 7.69万 - 项目类别:
Operating Grants
Novel pathways in T lymphocyte differentiation and function
T 淋巴细胞分化和功能的新途径
- 批准号:
RGPIN-2015-05491 - 财政年份:2021
- 资助金额:
$ 7.69万 - 项目类别:
Discovery Grants Program - Individual
Modulation of T lymphocyte Activation by ß2-Adrenergic Receptor Signalling Pathways
通过 α2-肾上腺素能受体信号通路调节 T 淋巴细胞激活
- 批准号:
RGPIN-2019-06980 - 财政年份:2021
- 资助金额:
$ 7.69万 - 项目类别:
Discovery Grants Program - Individual